DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Cunningham D, Humblet Y, Siena S. et al.
Cetuximab (C225) alone or in combination with irinotecan (CPT 11) in patients with epidermal growth factor receptor (EGFR) positive, irinotecan-refractory metastatic colorectal cancer (MCRC).
Proc Am Soc Clin Oncol 2003; 22: 253-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.